Iain Brown
Plus aucun poste en cours
Fortune : 3 M $ au 31/03/2024
Profil
Iain Michael Brown occupe le poste de Senior VP, Chief Financial & Accounting Officer chez Alkermes Plc. Au cours de sa carrière antérieure, M. Brown a occupé le poste de vice-président des finances chez Alkermes, Inc. et celui de vice-président des finances chez EMD Serono, Inc. Il a obtenu un diplôme de premier cycle à l'université de Bradford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/02/2024 | 116 344 ( 0,07% ) | 3 M $ | 31/03/2024 |
Anciens postes connus de Iain Brown
| Sociétés | Poste | Fin |
|---|---|---|
| ALKERMES PLC | Director of Finance/CFO | 01/02/2024 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Director of Finance/CFO | 16/09/2011 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Director of Finance/CFO | - |
Formation de Iain Brown
| University of Bradford | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALKERMES PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
